Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 06 Jan 2025

Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study

in Multiple Sclerosis and Neuroimmunology

André Aires Fernandes
Ana Lídia Neves
Daniela Ferro
Mafalda Seabra
Teresa Mendonça
Ricardo Soares dos Reis
Maria José Sá
Joana Guimarães
Pedro Abreu

Frontiers in Neurology

doi 10.3389/fneur.2024.1500763

1,965 views

Original Research

Published on 03 Jan 2025

Thalamic volume differentiates multiple sclerosis from neuromyelitis optica spectrum disorder: MRI-based retrospective study

in Multiple Sclerosis and Neuroimmunology

Manal Alosaimi
Hatham Alkanhal
Saleh Aldeligan
Nuha Alkhawajah
Alaa Albishi
Bander Hilabi
Salman Aljarallah

Frontiers in Neurology

doi 10.3389/fneur.2024.1491193

1,117 views

Perspective

Published on 31 Dec 2024

Diagnostic potential of blood-based biomarkers in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Signe Holm Nielsen
Morten Karsdal
Bruna Manoel
Anne-Christine Bay-Jensen
Kim Henriksen

Frontiers in Neurology

doi 10.3389/fneur.2024.1425046

907 views

Systematic Review

Published on 17 Dec 2024

The prevalence of obstructive sleep apnea-hypopnea syndrome in patients with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Peipei Li
Jiaqi Liu
Jianying Yang
Jie He
Jiaqing Jiang

Frontiers in Neurology

doi 10.3389/fneur.2024.1444470

1,177 views

Review

Published on 17 Dec 2024

Unraveling Alzheimer’s disease: insights from single-cell sequencing and spatial transcriptomic

in Multiple Sclerosis and Neuroimmunology

Yibo He
Wenqiang Lu
Xiao Zhou
Jie Mu
Wei Shen

Frontiers in Neurology

doi 10.3389/fneur.2024.1515981

1,963 views
2 citations

Perspective

Published on 13 Dec 2024

Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

in Multiple Sclerosis and Neuroimmunology

Domenico A. Restivo
Angelo Quartarone
Antongiulio Bruschetta
Angelo Alito
Demetrio Milardi
Rosario Marchese-Ragona
Ennio Iezzi
Sheila Peter
Diego Centonze
Mario Stampanoni Bassi

Frontiers in Neurology

doi 10.3389/fneur.2024.1514644

1,864 views

Original Research

Published on 13 Dec 2024

Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study

in Multiple Sclerosis and Neuroimmunology

Mohammed Bayounis
Mohammed Bin Mahfooz
Mohammed Assiri
Yousef Alghamdi
Fahad Alturki
Mahdi Almutairi
Abdullah Alshelawy
Mohammed Alosaimi
Faisal Almutawa
Abdulrahman Alammar

Frontiers in Neurology

doi 10.3389/fneur.2024.1492678

1,249 views

Original Research

Published on 11 Dec 2024

Cranial volume measurement with artificial intelligence and cognitive scales in patients with clinically isolated syndrome

in Multiple Sclerosis and Neuroimmunology

Özlem Albuz
Ibrahim Acir
Ozan Haşimoğlu
Melis Suskun
Elif Hocaoğlu
Vildan Yayla

Frontiers in Neurology

doi 10.3389/fneur.2024.1500140

1,125 views

Original Research

Published on 11 Dec 2024

Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population

in Multiple Sclerosis and Neuroimmunology

Peng Liu
Mengna Li
Liqing Li
Wenli Jia
Huimin Dong
Guoyan Qi

Frontiers in Neurology

doi 10.3389/fneur.2024.1482932

759 views

Original Research

Published on 09 Dec 2024

MOGAD and NMOSD: insights on patients’ radiological and laboratory findings from a single UAE center

in Multiple Sclerosis and Neuroimmunology

Hamdan Alzarooni
Jihad Inshasi
Ahmad Alawadhi
Paul Giacomini

Frontiers in Neurology

doi 10.3389/fneur.2024.1480723

1,349 views

Systematic Review

Published on 06 Dec 2024

Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials

in Multiple Sclerosis and Neuroimmunology

Eoin Moloney
Atefeh Mashayekhi
Sakshi Sharma
Vasileios Kontogiannis
Amir Ansaripour
Wallace Brownlee
David Paling
Mehdi Javanbakht

Frontiers in Neurology

doi 10.3389/fneur.2024.1479476

1,951 views

Original Research

Published on 04 Dec 2024

Integrative multi-omics approach using random forest and artificial neural network models for early diagnosis and immune infiltration characterization in ischemic stroke

in Multiple Sclerosis and Neuroimmunology

Ling Lin
Chunmao Guo
Hanna Jin
Haixiong Huang
Fan Luo
Ying Wang
Dongqi Li
Yuanxin Zhang
Yuqian Xu
Chanyan Zhu

Frontiers in Neurology

doi 10.3389/fneur.2024.1475582

1,763 views
1 citation

Original Research

Published on 27 Nov 2024

Combining gene expression microarrays and Mendelian randomization: exploring key immune-related genes in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Shuangfeng Ding
Yunyun Zhang
Yunzhe Tang
Ying Zhang
Mingyuan Liu

Frontiers in Neurology

doi 10.3389/fneur.2024.1437778

1,728 views
1 citation

Systematic Review

Published on 26 Nov 2024

Comparison of different exercise modalities on fatigue and muscular fitness in patients with multiple sclerosis: a systematic review with network, and dose–response meta-analyses

in Multiple Sclerosis and Neuroimmunology

Xi-Nuan Zhang
Zhi-De Liang
Ming-Da Li

Frontiers in Neurology

doi 10.3389/fneur.2024.1494368

1,693 views

Review

Published on 20 Nov 2024

Unveiling the fate and potential neuroprotective role of neural stem/progenitor cells in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Nora Hijal
Malak Fouani
Bassel Awada

Frontiers in Neurology

doi 10.3389/fneur.2024.1438404

1,287 views
1 citation

Original Research

Published on 19 Nov 2024

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation

in Multiple Sclerosis and Neuroimmunology

Fangyi Shi
Jiaxin Chen
Li Feng
Rong Lai
Hongyan Zhou
Xunsha Sun
Cunzhou Shen
Jiezhen Feng
Huiyu Feng
Haiyan Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1486659

1,672 views
1 citation